Literature DB >> 34998951

A case study and proposal for publishing directed acyclic graphs: The effectiveness of the quadrivalent human papillomavirus vaccine in perinatally HIV Infected girls.

Ruby Barnard-Mayers1, Hiba Kouser2, Jamie A Cohen3, Katherine Tassiopoulos4, Ellen C Caniglia5, Anna-Barbara Moscicki6, Nicole G Campos7, Michelle R Caunca8, George R Seage Seage4, Eleanor J Murray9.   

Abstract

BACKGROUND: Developing a causal graph is an important step in etiologic research planning and can be used to highlight data flaws and irreparable bias and confounding. As a case study, we consider recent findings that suggest human papillomavirus (HPV) vaccine is less effective against HPV-associated disease among girls living with HIV compared to girls without HIV.
OBJECTIVES: To understand the relationship between HIV status and HPV vaccine effectiveness, it is important to outline the key assumptions of the causal mechanisms before designing a study to investigate the effect of the HPV vaccine in girls living with HIV infection.
METHODS: We present a causal graph to describe our assumptions and proposed approach to explore this relationship. We hope to obtain feedback on our assumptions before data analysis and exemplify the process for designing causal graphs to inform an etiologic study.
CONCLUSION: The approach we lay out in this paper may be useful for other researchers who have an interest in using causal graphs to describe and assess assumptions in their own research before undergoing data collection and/or analysis.
Copyright © 2022. Published by Elsevier Inc.

Entities:  

Keywords:  Causal graphs; Directed acyclic graphs; HPV vaccine; Human immunodeficiency virus; Human papillomavirus

Mesh:

Substances:

Year:  2022        PMID: 34998951      PMCID: PMC8977269          DOI: 10.1016/j.jclinepi.2021.12.028

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   7.407


  33 in total

1.  A review of human carcinogens--Part B: biological agents.

Authors:  Véronique Bouvard; Robert Baan; Kurt Straif; Yann Grosse; Béatrice Secretan; Fatiha El Ghissassi; Lamia Benbrahim-Tallaa; Neela Guha; Crystal Freeman; Laurent Galichet; Vincent Cogliano
Journal:  Lancet Oncol       Date:  2009-04       Impact factor: 41.316

2.  Invited Commentary: Causal diagrams and measurement bias.

Authors:  Miguel A Hernán; Stephen R Cole
Journal:  Am J Epidemiol       Date:  2009-09-15       Impact factor: 4.897

3.  Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18.

Authors:  Dennis Dias; Jeff Van Doren; Sonela Schlottmann; Sheri Kelly; Derek Puchalski; Wanda Ruiz; Patricia Boerckel; Joseph Kessler; Joseph M Antonello; Tina Green; Martha Brown; Judith Smith; Narendra Chirmule; Eliav Barr; Kathrin U Jansen; Mark T Esser
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

Review 4.  Chapter 16: HPV vaccines in immunocompromised women and men.

Authors:  Joel M Palefsky; Maura L Gillison; Howard D Strickler
Journal:  Vaccine       Date:  2006-06-23       Impact factor: 3.641

Review 5.  Carcinogenic human papillomavirus infection.

Authors:  Mark Schiffman; John Doorbar; Nicolas Wentzensen; Silvia de Sanjosé; Carole Fakhry; Bradley J Monk; Margaret A Stanley; Silvia Franceschi
Journal:  Nat Rev Dis Primers       Date:  2016-12-01       Impact factor: 52.329

6.  End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age.

Authors:  X Castellsagué; N Muñoz; P Pitisuttithum; D Ferris; J Monsonego; K Ault; J Luna; E Myers; S Mallary; O M Bautista; J Bryan; S Vuocolo; R M Haupt; A Saah
Journal:  Br J Cancer       Date:  2011-05-31       Impact factor: 7.640

7.  Assessing knowledge, attitudes, and practices towards causal directed acyclic graphs: a qualitative research project.

Authors:  Ruby Barnard-Mayers; Ellen Childs; Laura Corlin; Ellen C Caniglia; Matthew P Fox; John P Donnelly; Eleanor J Murray
Journal:  Eur J Epidemiol       Date:  2021-06-10       Impact factor: 12.434

Review 8.  HPV vaccination in HIV infection.

Authors:  Charles Jn Lacey
Journal:  Papillomavirus Res       Date:  2019-06-25

9.  Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study.

Authors:  Kimberley Kavanagh; Kevin G Pollock; Kate Cuschieri; Tim Palmer; Ross L Cameron; Cameron Watt; Ramya Bhatia; Catherine Moore; Heather Cubie; Margaret Cruickshank; Chris Robertson
Journal:  Lancet Infect Dis       Date:  2017-09-28       Impact factor: 25.071

Review 10.  Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis.

Authors:  Helen Kelly; Helen A Weiss; Yolanda Benavente; Silvia de Sanjose; Philippe Mayaud
Journal:  Lancet HIV       Date:  2017-10-26       Impact factor: 12.767

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.